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Aims: Arterial hypoxemia stimulates free radical formation. Cellular studies suggest this may be implicated in coagulation activation, though human evidence is lacking. To examine this, an observational study was designed to explore relationships between systemic oxidative stress and haemostasic responses in healthy participants exposed to inspiratory hypoxia.
Results: Activated partial thromboplastin time and International Normalised Ratio were measured as routine, clinical biomarkers of coagulation and ascorbate free radical (A•-) as a direct, global biomarker of free radical flux. Six hours of hypoxia activated coagulation and increased formation of A•-, with inverse correlations observed against oxyhaemoglobin saturation.












Hypoxia increases the reduction state of mitochondrial electron transport carriers, favouring leakage of the superoxide anion [1]. Recently, it has been established in-vitro that an increase in reactive oxygen species (ROS) formation activates coagulation [2]. Though the underlying mechanisms remain unclear, it has been suggested that NADPH oxidase-mediated ROS formation within the vessel wall where tissue factor resides may be implicated, given that tissue factor expression per se is sensitive to ROS [3]. Equally, it has also been suggested that coagulation factor VIII bioactivity may be involved given that it too is subject to redox regulation [4].
Arterial hypoxaemia is a hallmark feature of patients with congestive heart failure, peripheral arterial occlusive disease, chronic obstructive lung disease and obstructive sleep apnoea [5]. These conditions are associated with increased all-cause cerebrovascular and cardiovascular mortality [6]. Traditionally, activated coagulation has been attributed to systemic inflammation [6 7] with no consideration for alternative, arguably “upstream”, redox-active pathways. 
Given this lack of information, we designed a “proof-of-concept” study in healthy participants in order to isolate the independent metabolic impact of hypoxia and identify to what extent redox function and haemostasis are altered and potentially related. We utilised inspiratory hypoxia to reduce the healthy participants’ arterial oxygen tension to a level similar to that of the circulatory-compromised patient population for six hours, as a simulated model of disease without any confounding comorbidities. We hypothesised that (a) inspiratory hypoxia would increase systemic free radical formation and activate coagulation, confirmed by an elevation in A•- and shortened activated partial thromboplastin time (aPTT) and (b) that both oxidative and haemostatic stress would be inversely related to the degree of arterial hypoxaemia reflected by the reduction in arterial oxyhaemoglobin saturation (SaO2).
Methodology

Subjects: Based on a simple 2-sided t-test comparing means, and assuming a 5% significance level, 90% power and (average) effect size of 1.15 on primary outcome variables (aPTT and A•-) we required 16 participants in each arm (normoxia and hypoxia) for analysis (calculated using nQuery v4.0). Due to incomplete data sets and dropout, data are presented on thirteen healthy men aged 25 ± 1 (mean ± S.E.M). A retrospective power analysis (SPSS statistics 21, IBM, Edinburgh, UK) revealed that the primary outcome variables (aPTT and A•-) were powered at 0.875 and 1.00 respectively when computed using an α-level of 0.05.
Participants with a known pre-existing coagulopathy or with pre-diagnosed risk factors for vascular disease were excluded. Volunteers who were taking any regular medication known to affect the oxidative, inflammatory or coagulation systems were excluded and also those who habitually ingested dietary vitamin supplements or who refused to cease supplementation 8 weeks prior to testing.
 
Experimental design: Baseline measurements were obtained at rest following a 12 hour overnight fast both in normoxia (FIO2 of 21%) and following 6 hours exposure to normobaric hypoxia (FIO2 of 12%) in a thermo-neutral environmental chamber (Weiss Technik, Ebbw Vale, UK).





where ISI is the international sensitivity index and  is provided by the reagent manufacturer, distinct to the batch.

Oxidative stress: Electron paramagnetic resonance (EPR) spectroscopy was used to directly measure ascorbate free radical (A•-) as a biomarker of global free radical formation [8]. Exactly 1 mL of K-EDTA plasma was injected into a high-sensitivity multiple-bore sample cell (AquaX, Bruker Daltonics Inc., Billerica, MA, USA) housed within a TM110 cavity of an electron paramagnetic resonance (EPR) spectrometer operating at X-band (9.87 GHz). Samples were analysed using a modulation frequency of 100 kilohertz (kHz), modulation amplitude of 0.65 gauss (G), microwave power of 10 milliwatt (mW), receiver gain of 2×105 AU, time constant of 41 ms, magnetic field centre of 3477 Gand scan width of ± 50 gauss (G) for three incremental scans. After identical baseline correction and filtering, each of the spectra were subject to double integration using graphical analysis software (OriginLab Pro, version 8.5, OriginLab Corporation, MA, USA). The intra and inter-assay CV’s were both <5 %.

Cardiovascular: Arterial haemoglobin oxygen saturation (SaO2) was determined using finger-tip pulse oximetry (Novametrix 515C, Philips Healthcare, Guilford, UK).
















































This is the first study that has investigated the potential relationship between systemic hypoxaemia, oxidative stress and activation of coagulation in humans. Normobaric hypoxia was employed to simulate an arterial oxygen tension equivalent to that experienced by patients with vascular disease in order to isolate the metabolic impact of hypoxia without the potential confounds associated with related comorbidities. INR and aPTT were utilised as markers of coagulation routinely employed in a clinical environment.
Given that the concentration of ascorbate in human plasma is orders of magnitude greater than any oxidising free radical, combined with the low one-electron reduction potential (E΄ = 282 mV) associated with the A•-/ascorbate monanion (AH-) couple [9], any radical generated within the systemic circulation has the potential to react endogenously with this terminal small-molecule antioxidant to form the distinctive A•- EPR doublet [(R• + AH-  A•- + R-H] [10]. Thus, the elevation in A•- combined with the inverse relationship with SaO2 provides direct evidence that hypoxaemia increased free radical-mediated oxidative stress. 


























































































































































Arterial hypoxaemia is associated with increased all-cause cardiovascular mortality.

Hypoxaemia per se initiates both oxidative stress and coagulation in-vivo.
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Table 1: Changes in activated partial thromboplastin time (aPTT), international normalised ratio (INR), arterial haemoglobin oxygen saturation () and plasma ascorbate free radical (). Values are expressed as means ± standard error; * different from normoxia (P < 0.05).
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